Skip to main content
Erschienen in: Drug Safety 5/2011

01.05.2011 | Original Research Article

Mortality Rates and Causes of Death in Children with Epilepsy Prescribed Antiepileptic Drugs

A Retrospective Cohort Study using the UK General Practice Research Database

verfasst von: Ruth Ackers, Frank M.C. Besag, Elaine Hughes, Waney Squier, Macey L. Murray, Professor Ian C.K. Wong

Erschienen in: Drug Safety | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Background: Patients with epilepsy, including children, have an increased risk of mortality compared with the general population. Antiepileptic drugs (AEDs) were the most frequent class of drugs reported in a study looking at fatal suspected adverse drug reactions in children in the UK.
Objective: The objective of the study was to identify cases and causes of death in a paediatric patient cohort prescribed AEDs with an associated epilepsy diagnosis.
Methods: This was a retrospective cohort study supplemented with general practitioner-completed questionnaires, post-mortem reports and death certificates. The setting was UK primary care practices contributing to the General Practice Research Database. Participants were children and adolescents aged 0–18 years prescribed AEDs between 1993 and 2005. Causality assessment was undertaken by a consensus panel comprising paediatric specialists in neuropathology, neurology, neuropsychiatry, paediatric epilepsy, pharmacoepidemiology and pharmacy to determine crude mortality rate (CMR) and standardized mortality ratios (SMRs), and the likelihood of an association between AED(s) and the event of death.
Results: There were 6190 subjects in the cohort (contributing 26 890 person-years of data), of whom 151 died. Median age at death was 8.0 years. CMR was 56.2 per 10000 person-years and the SMR was 22.4 (95% CI 18.9, 26.2). The majority of deceased subjects had severe underlying disorders. Death was attributable to epilepsy in 18 subjects; in 9 the cause of death was sudden unexpected death in epilepsy (SUDEP) [3.3 per 10 000 person-years (95% CI 1.5, 6.4)]. AEDs were probably (n = 2) or possibly (n = 3) associated causally with death in five subjects. Two status epilepticus deaths were associated causally with AED withdrawal.
Conclusions: Children prescribed AEDs have an increased risk of mortality relative to the general population. Most of the deaths were in children with serious underlying disorders. A small number of SUDEP cases were identified. AEDs are not a major cause of death but in a small proportion of cases, a causal relationship between death and AEDs could not be excluded.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Clarkson A, Choonara I. Surveillance for fatal suspected adverse drug reactions in the UK. Arch Dis Child 2002; 87: 462–7PubMedCrossRef Clarkson A, Choonara I. Surveillance for fatal suspected adverse drug reactions in the UK. Arch Dis Child 2002; 87: 462–7PubMedCrossRef
3.
Zurück zum Zitat Ackers R, Murray M, Besag F, et al. Prioritizing children’s medicines for research: a pharmacoepidemiological study on newer antiepileptic drugs. Br J Clin Pharmacol 2007; 63(6): 689–97PubMedCrossRef Ackers R, Murray M, Besag F, et al. Prioritizing children’s medicines for research: a pharmacoepidemiological study on newer antiepileptic drugs. Br J Clin Pharmacol 2007; 63(6): 689–97PubMedCrossRef
4.
Zurück zum Zitat Hollowell J. The general practice research database: quality of morbidity data. Popul Trends 1997; 87: 36–40PubMed Hollowell J. The general practice research database: quality of morbidity data. Popul Trends 1997; 87: 36–40PubMed
5.
Zurück zum Zitat Wong IC, Murray ML. The potential of UK clinical databases in enhancing paediatric medication research. Br J Clin Pharmacol 2005; 59(6): 750–5PubMedCrossRef Wong IC, Murray ML. The potential of UK clinical databases in enhancing paediatric medication research. Br J Clin Pharmacol 2005; 59(6): 750–5PubMedCrossRef
6.
Zurück zum Zitat Rani F, Murray ML, Byrne PJ, et al. Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics 2008; 121: 1002–9PubMedCrossRef Rani F, Murray ML, Byrne PJ, et al. Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics 2008; 121: 1002–9PubMedCrossRef
7.
Zurück zum Zitat McCarthy S, Asherson P, Coghill D, et al. Trends in prescribing prevalence and cessation of ADHD drug treatment among adolescents and young adults in the United Kingdom. Br J Psychiatry 2009; 194(3): 273–7PubMedCrossRef McCarthy S, Asherson P, Coghill D, et al. Trends in prescribing prevalence and cessation of ADHD drug treatment among adolescents and young adults in the United Kingdom. Br J Psychiatry 2009; 194(3): 273–7PubMedCrossRef
8.
Zurück zum Zitat Thompson PL, Gilbert R, Long PF, et al. Effect of antibiotics for otitis media on mastoiditis in children: a retrospective cohort study using the UK General Practice Research Database. Pediatrics 2009; 123: 424–30PubMedCrossRef Thompson PL, Gilbert R, Long PF, et al. Effect of antibiotics for otitis media on mastoiditis in children: a retrospective cohort study using the UK General Practice Research Database. Pediatrics 2009; 123: 424–30PubMedCrossRef
9.
Zurück zum Zitat Derby LE, Tennis P, Jick H. Sudden unexplained death among subjects with refractory epilepsy. Epilepsia 1996; 37(10): 931–5PubMedCrossRef Derby LE, Tennis P, Jick H. Sudden unexplained death among subjects with refractory epilepsy. Epilepsia 1996; 37(10): 931–5PubMedCrossRef
10.
Zurück zum Zitat McCarthy S, Cranswick N, Potts L, et al. Mortality associated with attention deficit hyperactivity disorder (ADHD) drug treatment. Drug Saf 2009; 32(11): 1089–96PubMedCrossRef McCarthy S, Cranswick N, Potts L, et al. Mortality associated with attention deficit hyperactivity disorder (ADHD) drug treatment. Drug Saf 2009; 32(11): 1089–96PubMedCrossRef
14.
Zurück zum Zitat Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255–9PubMedCrossRef Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255–9PubMedCrossRef
15.
Zurück zum Zitat Hanna NJ, Black M, Sander JWS, et al. The national sentinel clinical audit of epilepsy-related death: epilepsy-death in the shadows. London: The Stationery Office, 2002 Hanna NJ, Black M, Sander JWS, et al. The national sentinel clinical audit of epilepsy-related death: epilepsy-death in the shadows. London: The Stationery Office, 2002
16.
Zurück zum Zitat Nashef L. Sudden unexpected death in epilepsy: terminology and definitions. Epilepsia 1997; 38: S6–8PubMedCrossRef Nashef L. Sudden unexpected death in epilepsy: terminology and definitions. Epilepsia 1997; 38: S6–8PubMedCrossRef
17.
Zurück zum Zitat Bland M. An introduction to medical statistics. London: Oxford University Press, 1993 Bland M. An introduction to medical statistics. London: Oxford University Press, 1993
18.
Zurück zum Zitat Berg AT, Shinnar S, Testa FM, et al. Mortality in childhood-onset epilepsy. Arch Pediatr Adolesc Med 2004; 158: 1147–52PubMedCrossRef Berg AT, Shinnar S, Testa FM, et al. Mortality in childhood-onset epilepsy. Arch Pediatr Adolesc Med 2004; 158: 1147–52PubMedCrossRef
19.
Zurück zum Zitat Callenbach PM, Westendorp RG, Geerts AT, et al. Mortality risk in children with epilepsy: the Dutch Study of Epilepsy in Childhood. Pediatrics 2001; 107(6): 1259–63PubMedCrossRef Callenbach PM, Westendorp RG, Geerts AT, et al. Mortality risk in children with epilepsy: the Dutch Study of Epilepsy in Childhood. Pediatrics 2001; 107(6): 1259–63PubMedCrossRef
20.
Zurück zum Zitat Harvey AS, Nolan T, Carlin JB. Community-based study of mortality in children with epilepsy. Epilepsia 1993; 34(4): 597–603PubMedCrossRef Harvey AS, Nolan T, Carlin JB. Community-based study of mortality in children with epilepsy. Epilepsia 1993; 34(4): 597–603PubMedCrossRef
21.
Zurück zum Zitat Sillanpaa M, Jalava M, Kaleva O, et al. Long-term prognosis of seizures with onset in childhood. N Engl J Med 1998; 338(24): 1715–23PubMedCrossRef Sillanpaa M, Jalava M, Kaleva O, et al. Long-term prognosis of seizures with onset in childhood. N Engl J Med 1998; 338(24): 1715–23PubMedCrossRef
22.
Zurück zum Zitat Werlin SL, Fish DL. The spectrum of valproic acid-associated pancreatitis. Pediatrics 2006; 118(4): 1660–3PubMedCrossRef Werlin SL, Fish DL. The spectrum of valproic acid-associated pancreatitis. Pediatrics 2006; 118(4): 1660–3PubMedCrossRef
23.
Zurück zum Zitat Chapman SA, Wacksman GP, Patterson BD. Pancreatitis associated with valproic acid: a review of the literature. Pharmacotherapy 2001; 21(12): 1549–60PubMedCrossRef Chapman SA, Wacksman GP, Patterson BD. Pancreatitis associated with valproic acid: a review of the literature. Pharmacotherapy 2001; 21(12): 1549–60PubMedCrossRef
24.
Zurück zum Zitat Asconape JJ, Penry JK, Dreifuss FE, et al. Valproate associated pancreatitis. Epilepsia 1993; 34(1): 177–83PubMedCrossRef Asconape JJ, Penry JK, Dreifuss FE, et al. Valproate associated pancreatitis. Epilepsia 1993; 34(1): 177–83PubMedCrossRef
25.
Zurück zum Zitat Bell GS, Gaitatzis A, Johnson AL, et al. Predictive value of death certification in the case ascertainment of epilepsy. J Neurol Neurosurg Psychiatry 2004; 75(12): 1756–8PubMedCrossRef Bell GS, Gaitatzis A, Johnson AL, et al. Predictive value of death certification in the case ascertainment of epilepsy. J Neurol Neurosurg Psychiatry 2004; 75(12): 1756–8PubMedCrossRef
26.
Zurück zum Zitat Camfield CS, Camfield PR, Veugelers PJ. Death in children with epilepsy: a population-based study. Lancet 2002; 359: 1891–5PubMedCrossRef Camfield CS, Camfield PR, Veugelers PJ. Death in children with epilepsy: a population-based study. Lancet 2002; 359: 1891–5PubMedCrossRef
27.
Zurück zum Zitat Nashef L, Fish DR, Garner S, et al. Sudden death in epilepsy: a study of incidence in a young cohort with epilepsy and learning difficulty. Epilepsia 1995; 36(12): 1187–94PubMedCrossRef Nashef L, Fish DR, Garner S, et al. Sudden death in epilepsy: a study of incidence in a young cohort with epilepsy and learning difficulty. Epilepsia 1995; 36(12): 1187–94PubMedCrossRef
28.
Zurück zum Zitat Stokes T, Shaw EJ, Juarez-Garcia A, et al. Clinical guidelines and evidence review for the epilepsies: diagnosis and management in adults and children in primary and secondary care. London: Royal College of General Practitioners, 2004 Stokes T, Shaw EJ, Juarez-Garcia A, et al. Clinical guidelines and evidence review for the epilepsies: diagnosis and management in adults and children in primary and secondary care. London: Royal College of General Practitioners, 2004
29.
Zurück zum Zitat Brorson LO, Wranne L. Long-term prognosis in childhood epilepsy: survival and seizure prognosis. Epilepsia 1987; 28(4): 324–30PubMedCrossRef Brorson LO, Wranne L. Long-term prognosis in childhood epilepsy: survival and seizure prognosis. Epilepsia 1987; 28(4): 324–30PubMedCrossRef
30.
Zurück zum Zitat Donner EJ, Smith CR, Snead OC. Sudden unexplained death in children with epilepsy. Neurology 2001; 57: 430–4PubMedCrossRef Donner EJ, Smith CR, Snead OC. Sudden unexplained death in children with epilepsy. Neurology 2001; 57: 430–4PubMedCrossRef
31.
Zurück zum Zitat British Medical Association, Royal Pharmaceutical Society of Great Britain, Royal College of Paediatricians and Child Health. British national formulary for children (BNFC). London: BMJ Publishing Group Ltd, RPS Publishing, RCPCH Publications Ltd, 2008 British Medical Association, Royal Pharmaceutical Society of Great Britain, Royal College of Paediatricians and Child Health. British national formulary for children (BNFC). London: BMJ Publishing Group Ltd, RPS Publishing, RCPCH Publications Ltd, 2008
32.
Zurück zum Zitat Wong ICK, Lhatoo SD. Adverse reactions to new anti-convulsant drugs. Drug Saf 2000; 23(1): 35–56PubMedCrossRef Wong ICK, Lhatoo SD. Adverse reactions to new anti-convulsant drugs. Drug Saf 2000; 23(1): 35–56PubMedCrossRef
33.
Zurück zum Zitat Wong ICK, Mawer GE, Sander JWAS. Vigabatrin and visual field constriction. BMJ 1997; 314: 1693–4PubMed Wong ICK, Mawer GE, Sander JWAS. Vigabatrin and visual field constriction. BMJ 1997; 314: 1693–4PubMed
34.
Zurück zum Zitat Langan Y, Nashef L, Sander JW. Case-control study of SUDEP. Neurology 2005 12; 64(7): 1131–3PubMedCrossRef Langan Y, Nashef L, Sander JW. Case-control study of SUDEP. Neurology 2005 12; 64(7): 1131–3PubMedCrossRef
Metadaten
Titel
Mortality Rates and Causes of Death in Children with Epilepsy Prescribed Antiepileptic Drugs
A Retrospective Cohort Study using the UK General Practice Research Database
verfasst von
Ruth Ackers
Frank M.C. Besag
Elaine Hughes
Waney Squier
Macey L. Murray
Professor Ian C.K. Wong
Publikationsdatum
01.05.2011
Verlag
Springer International Publishing
Erschienen in
Drug Safety / Ausgabe 5/2011
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI
https://doi.org/10.2165/11588480-000000000-00000

Weitere Artikel der Ausgabe 5/2011

Drug Safety 5/2011 Zur Ausgabe